AI Leaders Urge Mandatory DNA Screening
Get the Tech newsletter
Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.
- Sam Altman (OpenAI) signed an open letter urging US lawmakers to require mandatory screening of synthetic DNA and RNA purchases for sequences that could be used to create dangerous pathogens.
- Dario Amodei (Anthropic) also signed, warning that AI tools could make it easier to design harmful genetic sequences.
- Mustafa Suleyman (Microsoft) added his support, noting that AI‑driven design lowers barriers for non‑experts to create bio‑hazards.
- Alexandr Wang (Meta) co‑signed, emphasizing that many synthetic‑genetics providers currently screen orders only voluntarily.
- Demis Hassabis (Google DeepMind) also signed, calling for detailed record‑keeping of DNA/RNA orders to track threats that evade screening.
- Twist Bioscience (synthetic‑DNA seller) signed, supporting mandatory screening and record‑keeping for all orders.
- Foundation for American Innovation (think tank) organized the letter, describing the biosecurity gap as urgent given rapid AI and synthetic‑biology advances.
Why it matters: If Congress adopts the proposed rules, synthetic‑genetics companies such as Twist Bioscience and Ansa Biotechnologies would have to implement mandatory screening and detailed record‑keeping for every DNA/RNA order, tightening biosecurity but adding significant compliance costs, operational complexity, and possible delays to legitimate research and development.
